Advanced search×

Estrogen, aging and the cardiovascular system

Future Cardiol 5(1):93-103 (2009) PMID 19371207

Estrogen is a powerful hormone with pleiotropic effects. Estrogens have potent antioxidant effects and are able to reduce inflammation, induce vasorelaxation and alter gene expression in both the vasculature and the heart. Estrogen treatment of cultured cardiac myocytes and endothelial cells rapidly activates NFkappaB, induces heat-shock protein (HSP)-72, a potent intracellular protective protein, and protects cells from simulated ischemia. In in vivo models, estrogens protect against ischemia and trauma/hemorrhage. Estrogens may decrease the expression of soluble epoxide hydrolase, which has deleterious effects on the cardiovascular system through metabolism of epoxyeicosatrienoic acids. Natural (endogenous) estrogens in premenopausal women appear to protect against cardiovascular disease and yet controlled clinical trials have not indicated a benefit from estrogen replacement postmenopause. Much remains to be understood in regards to the many properties of this powerful hormone and how changes in this hormone interact with aging-associated changes. The unexpected negative results of trials of estrogen replacement postmenopause probably arise from our lack of understanding of the many effects of this hormone.

DOI: 10.2217/14796678.5.1.93
Version: za2963e q8za5 q8zbd q8zc5 q8zdd q8zed q8zfc q8zgd

Similar articles you may find interesting…

  1. Making sense of puzzling genetic association studies: a team approach.

    Ann Intern Med 145(4):302-4 (2006) PMID 16908922

  2. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.

    Cancer Epidemiol Biomarkers Prev 15(2):359-63 (2006) PMID 16492929

    In families of patients who were negative or untested for BRCA1 or BRCA2 mutations, risks were elevated only for the patient's cancer site. The breast cancer SIR was 1.5 (95% CI, 1.2-1.8) for relatives of breast cancer patients, compared with 1.1 (95% CI, 0.8-1.6) for relatives of ovarian cancer pat...
  3. Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study.

    Cancer Epidemiol Biomarkers Prev 14(5):1047-51 (2005) PMID 15894651

    High serum testosterone and advanced education predicted ER+ breast cancer. If confirmed, high testosterone level may be more accurate than family history of breast cancer and other conventional risk factors for identifying older women who are most likely to benefit from antiestrogen chemoprevention...